Background: GSA announced its intent to prepare an Environmental Impact Statement (EIS) for the proposed Master Plan (the plan) to support the consolidation of the U.S. Food and Drug Administration (FDA) Headquarters at the Federal Research Center (the FRC) at White Oak in Silver Spring, Maryland. Since 1997, there have been ongoing discussions and plans of the consolidation of FDA employees at the FRC. This EIS will examine the impacts of increasing the number of workers at the FRC by 18,000 over a 15-year period. It should assess such needs as laboratory space, office space, and any infrastructure necessary to accommodate the increase in the employee population at the FRC. The GSA plans to hold a public scoping meeting to receive comments. The meeting will be held on September 12, 2017 from 6:30pm to 8:30pm EDT at CHI Center, 10501 New Hampshire Avenue, Silver Spring, Maryland 20903.
Written comments regarding the environmental analysis for the proposed Master Plan must be postmarked between Monday, August 21, 2017, and Monday, September 25, 2017, and sent to the following address: General Services Administration, Public Buildings Service, Office of Planning and Design Quality, Attention: Paul Gyamfi, 301 7th Street SW., Room 4004, Washington, DC 20407. Email: email@example.com using the subject line: FDA White Oak Master Plan Comment.
To download the full PDF, click here.